Get the app!
Back to Trades

Dugel Pravin

See RemarksDirectorCIK 0001700917

Largest Purchase

No open-market purchases in the recent filings.

Profile

Filings
9
Buy transactions
0
Sell transactions
5
Companies
1
Active
2025–2026

Across 9 filings between 2025–2026, Dugel Pravin, See Remarks, Director, has disclosed $2.0M in transactions — all concentrated in OCULAR THERAPEUTIX, INC (OCUL). Their disclosed trades are heavily weighted toward selling$0 in buys and $2.0M in sells. Data is sourced from official SEC Form 3, 4, and 5 filings.

Trading History

9 loaded
Aug 26OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorSell$233.2K
Jun 18OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorGift$0
May 28OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorSell$173.5K
Apr 13OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorGift$0
Feb 25OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorSell$166.1K
Feb 17OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorSell$1.1M
Sep 11OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorGift$0
Aug 27OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorSell$258.8K
Aug 13OCUL
OCULAR THERAPEUTIX, INC
Dugel PravinSee Remarks, DirectorGift$0

9 filings